These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 28982299)
21. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Yu JT; Wang CY; Yang Y; Wang RC; Chang KH; Hwang WL; Teng CL Ann Hematol; 2013 Nov; 92(11):1529-36. PubMed ID: 23700280 [TBL] [Abstract][Full Text] [Related]
22. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189 [TBL] [Abstract][Full Text] [Related]
23. Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation. Zou H; He L; Hue Z; Liu M; Yao S; Zhu Y; Wang Z; Wang Y J Cancer Res Clin Oncol; 2023 Sep; 149(11):8521-8533. PubMed ID: 37093345 [TBL] [Abstract][Full Text] [Related]
24. Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis. Yang CL; Chen X; Zhou HJ; Wu WC; Zou LQ J Hematol; 2024 Apr; 13(1-2):46-51. PubMed ID: 38644986 [TBL] [Abstract][Full Text] [Related]
25. Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis. Song Y; Wang J; Wang Y; Wu L; Wang Z Cancer Biol Ther; 2021 Dec; 22(10-12):598-606. PubMed ID: 34724875 [TBL] [Abstract][Full Text] [Related]
26. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome. Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447 [TBL] [Abstract][Full Text] [Related]
27. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis. Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280 [TBL] [Abstract][Full Text] [Related]
28. The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis. Jiang T; Ding X; Lu W Dis Markers; 2016; 2016():1523959. PubMed ID: 27110054 [TBL] [Abstract][Full Text] [Related]
30. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China. Li F; Li P; Zhang R; Yang G; Ji D; Huang X; Xu Q; Wei Y; Rao J; Huang R; Chen G Med Oncol; 2014 Apr; 31(4):902. PubMed ID: 24610542 [TBL] [Abstract][Full Text] [Related]
31. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma. Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074 [TBL] [Abstract][Full Text] [Related]
32. [The diagnostic value of flow cytometry in patients with lymphoma associated hemophagocytic syndrome]. Zhang WL; Xu L; Zhang Q; Zhong FL; Dai J; Feng J; Sun LH; Xu HC; Xie WY; Zhang HY Zhonghua Nei Ke Za Zhi; 2020 Dec; 59(12):976-981. PubMed ID: 33256339 [No Abstract] [Full Text] [Related]
33. [Clinical analysis of 14 patients with lymphoma associated hemophagocytic syndrome]. Wang JS; Wang Z; Wu L; Tian LP; Chen X Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1352-5. PubMed ID: 19840482 [TBL] [Abstract][Full Text] [Related]
35. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis. Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489 [TBL] [Abstract][Full Text] [Related]
36. Clinical and genetic characterization of Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases. Luo H; Liu D; Liu W; Jin J; Bi X; Zhang P; Gu J; Zheng M; Xiao M; Liu X; Zhou J; Wang QF J Allergy Clin Immunol; 2023 Apr; 151(4):1096-1109. PubMed ID: 36423698 [TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900 [TBL] [Abstract][Full Text] [Related]
38. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis. Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406 [TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood]. Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937 [TBL] [Abstract][Full Text] [Related]
40. Elevation of CD16 Wang J; Han W; Gao Z; Wang Y; Wu L; Zhang J; Lai W; Wang Z Hematology; 2017 Sep; 22(8):477-483. PubMed ID: 28413901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]